Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults | Zendy

Romina Libster | Zendy; Gonzalo Pérez Marc | Zendy; Diego Wappner | Zendy; Silvina Coviello | Zendy; Alejandra Bianchi | Zendy; Virginia Braem | Zendy; Ignacio Esteban | Zendy; Mauricio T. Caballero | Zendy; Cristian Wood | Zendy; Mabel Berrueta | Zendy; Aníbal Rondan | Zendy; Gabriela Lescano | Zendy; Pablo Jordão Alcântara Cruz | Zendy; Yvonne Ritou | Zendy; Valeria Fernández Viña | Zendy; Damián Álvarez Paggi | Zendy; Sebastián Esperante | Zendy; Adrián Ferreti | Zendy; Gastón Ofman | Zendy; Álvaro Ciganda | Zendy; Rocío Rodríguez | Zendy; Jorge Lantos | Zendy; Ricardo Valentini | Zendy; Nicolás Itcovici | Zendy; Alejandra Hintze | Zendy; María Laura Oyarvide | Zendy; Candela Etchegaray | Zendy; Alejandra Neira | Zendy; Ivonne Name | Zendy; Julieta Alfonso | Zendy; Rocío López Castelo | Zendy; Gisela Caruso | Zendy; Sofía Rapelius | Zendy; Fernando Alvez | Zendy; Federico Etchenique | Zendy; Federico Dimase | Zendy; Darío Alvarez | Zendy; Sofía S. Aranda | Zendy; Clara Sánchez Yanotti | Zendy; Julián De Luca | Zendy; Sofía Jares Baglivo | Zendy; Sofía Laudanno | Zendy; Florencia Nowogrodzki | Zendy; Ramiro Larrea | Zendy; María Dolores Silveyra | Zendy; Gabriel Leberzstein | Zendy; Alejandra Debonis | Zendy; Juan Molinos | Zendy; Miguel Santiago Gonzalez | Zendy; Eduardo García Pérez | Zendy; Nicolás Kreplak | Zendy; Susana Pastor Argüello | Zendy; Luz Gibbons | Zendy; Fernando Althabe | Zendy; Eduardo Bergel | Zendy; Fernando P. Polack | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

Author(s) -

Romina Libster,

Gonzalo Pérez Marc,

Diego Wappner,

Silvina Coviello,

Alejandra Bianchi,

Virginia Braem,

Ignacio Esteban,

Mauricio T. Caballero,

Cristian Wood,

Mabel Berrueta,

Aníbal Rondan,

Gabriela Lescano,

Pablo Jordão Alcântara Cruz,

Yvonne Ritou,

Valeria Fernández Viña,

Damián Álvarez Paggi,

Sebastián Esperante,

Adrián Ferreti,

Gastón Ofman,

Álvaro Ciganda,

Rocío Rodríguez,

Jorge Lantos,

Ricardo Valentini,

Nicolás Itcovici,

Alejandra Hintze,

María Laura Oyarvide,

Candela Etchegaray,

Alejandra Neira,

Ivonne Name,

Julieta Alfonso,

Rocío López Castelo,

Gisela Caruso,

Sofía Rapelius,

Fernando Alvez,

Federico Etchenique,

Federico Dimase,

Darío Alvarez,

Sofía S. Aranda,

Clara Sánchez Yanotti,

Julián De Luca,

Sofía Jares Baglivo,

Sofía Laudanno,

Florencia Nowogrodzki,

Ramiro Larrea,

María Dolores Silveyra,

Gabriel Leberzstein,

Alejandra Debonis,

Juan Molinos,

Miguel Santiago Gonzalez,

Eduardo García Pérez,

Nicolás Kreplak,

Susana Pastor Argüello,

Luz Gibbons,

Fernando Althabe,

Eduardo Bergel,

Fernando P. Polack

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2033700

Subject(s) - medicine , placebo , relative risk , clinical endpoint , confidence interval , randomization , population , adverse effect , severe acute respiratory syndrome , randomized controlled trial , covid-19 , disease , infectious disease (medical specialty) , pathology , alternative medicine , environmental health

Therapies to interrupt the progression of early coronavirus disease 2019 (Covid-19) remain elusive. Among them, convalescent plasma administered to hospitalized patients has been unsuccessful, perhaps because antibodies should be administered earlier in the course of illness.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research